https://jamanetwork.com/journals/jama/fullarticle/2787944 Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue [Skip to Navigation] JAMA Network Home JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology-Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeAppsJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2022 American Medical Association. All Rights Reserved [Search All ] [ ] [ ] Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Subscribe to the JAMA journal Trending * Association Between Isolated Diastolic Hypertension Defined by the 2017 ACC/AHA Blood Pressure Guideline and Incident CVD Original Investigation January 28, 2020 * Noninvasive Positive Pressure Ventilation and Clinical Outcomes in Chronic Obstructive Pulmonary Disease Original Investigation February 4, 2020 Select Your Interests Customize your JAMA Network experience by selecting one or more topics from the list below. * Acid Base, Electrolytes, Fluids * Addiction Medicine * Allergy and Clinical Immunology * Anesthesiology * Anticoagulation * Art and Images in Psychiatry * Bleeding and Transfusion * Cardiology * Caring for the Critically Ill Patient * Challenges in Clinical Electrocardiography * Clinical Challenge * Clinical Decision Support * Clinical Implications of Basic Neuroscience * Clinical Pharmacy and Pharmacology * Complementary and Alternative Medicine * Consensus Statements * Coronavirus (COVID-19) * Critical Care Medicine * Cultural Competency * Dental Medicine * Dermatology * Diabetes and Endocrinology * Diagnostic Test Interpretation * Diversity, Equity, and Inclusion * Drug Development * Electronic Health Records * Emergency Medicine * End of Life * Environmental Health * Ethics * Facial Plastic Surgery * Gastroenterology and Hepatology * Genetics and Genomics * Genomics and Precision Health * Geriatrics * Global Health * Guide to Statistics and Medicine * Guidelines * Hair Disorders * Health Care Delivery Models * Health Care Economics, Insurance, Payment * Health Care Quality * Health Care Reform * Health Care Safety * Health Care Workforce * Health Disparities * Health Inequities * Health Informatics * Health Policy * Hematology * History of Medicine * Humanities * Hypertension * Images in Neurology * Implementation Science * Infectious Diseases * Innovations in Health Care Delivery * JAMA Infographic * Law and Medicine * Leading Change * Less is More * LGBTQ * Lifestyle Behaviors * Medical Coding * Medical Devices and Equipment * Medical Education * Medical Education and Training * Medical Journals and Publishing * Melanoma * Mobile Health and Telemedicine * Narrative Medicine * Nephrology * Neurology * Neuroscience and Psychiatry * Notable Notes * Nursing * Nutrition * Nutrition, Obesity, Exercise * Obesity * Obstetrics and Gynecology * Occupational Health * Oncology * Ophthalmic Images * Ophthalmology * Orthopedics * Otolaryngology * Pain Medicine * Pathology and Laboratory Medicine * Patient Care * Patient Information * Pediatrics * Performance Improvement * Performance Measures * Perioperative Care and Consultation * Pharmacoeconomics * Pharmacoepidemiology * Pharmacogenetics * Pharmacy and Clinical Pharmacology * Physical Medicine and Rehabilitation * Physical Therapy * Physician Leadership * Poetry * Population Health * Preventive Medicine * Professional Well-being * Professionalism * Psychiatry and Behavioral Health * Public Health * Pulmonary Medicine * Radiology * Regulatory Agencies * Research, Methods, Statistics * Resuscitation * Rheumatology * Risk Management * Scientific Discovery and the Future of Medicine * Shared Decision Making and Communication * Sleep Medicine * Sports Medicine * Stem Cell Transplantation * Surgery * Surgical Innovation * Surgical Pearls * Teachable Moment * Technology and Finance * The Art of JAMA * The Arts and Medicine * The Rational Clinical Examination * Tobacco and e-Cigarettes * Toxicology * Trauma and Injury * Treatment Adherence * Ultrasonography * Urology * Users' Guide to the Medical Literature * Vaccination * Venous Thromboembolism * Veterans Health * Violence * Women's Health * Workflow and Process * Wound Care, Infection, Healing Save Preferences Privacy Policy | Terms of Use Twitter Facebook More New Online Views 19,990 Citations 0 Comments 4 View Metrics * Download PDF * Share Twitter Facebook Email LinkedIn * Cite This * Permissions * Comment Viewpoint January 6, 2022 A National Strategy for the "New Normal" of Life With COVID Ezekiel J. Emanuel, MD, PhD^1; Michael Osterholm, PhD, MPH^2; Celine R. Gounder, MD, ScM^3 Author Affiliations Article Information * ^1Perelman School of Medicine and The Wharton School, University of Pennsylvania, Philadelphia * ^2Center for Infectious Disease Research and Policy, University of Minnesota, Minneapolis * ^3Grossman School of Medicine, New York University, New York, New York JAMA. Published online January 6, 2022. doi:10.1001/jama.2021.24282 COVID-19 Resource Center visual abstract icon Visual Abstract editorial comment icon Editorial Comment related articles icon Related Articles author interview icon Interviews multimedia icon Multimedia * Viewpoint The First 2 Years of COVID-19--Lessons to Improve Preparedness for the Next Pandemic Jennifer B. Nuzzo, DrPH, SM; Lawrence O. Gostin, JD * Viewpoint A National Strategy for COVID-19--Testing, Surveillance, and Mitigation Strategies David Michaels, PhD, MPH; Ezekiel J. Emanuel, MD, PhD; Rick A. Bright, PhD * Viewpoint A National Strategy for COVID-19 Medical Countermeasures Luciana L. Borio, MD; Rick A. Bright, PhD; Ezekiel J. Emanuel, MD, PhD * Viewpoint The Pandemic Preparedness Program Eli Y. Adashi, MD, MS; I. Glenn Cohen, JD As the Omicron variant of SARS-CoV-2 demonstrates, COVID-19 is here to stay. In January 2021, President Biden issued the "National Strategy for the COVID-19 Response and Pandemic Preparedness." As the US moves from crisis to control, this national strategy needs to be updated. Policy makers need to specify the goals and strategies for the "new normal" of life with COVID-19 and communicate them clearly to the public. SARS-CoV-2 continues to persist, evolve, and surprise. In July 2021, with vaccinations apace and infection rates plummeting, Biden proclaimed that "we've gained the upper hand against this virus," and the Centers for Disease Control and Prevention (CDC) relaxed its guidance for mask wearing and socializing.^1 By September 2021, the Delta variant proved these steps to be premature, and by late November, the Omicron variant created concern about a perpetual state of emergency. In delineating a national strategy, humility is essential. The precise duration of immunity to SARS-CoV-2 from vaccination or prior infection is unknown. Also unknown is whether SARS-CoV-2 will become a seasonal infection; whether antiviral therapies will prevent long COVID; or whether even more transmissible, immune-evading, or virulent variants will arise after Omicron. Another part of this humility is recognizing that predictions are necessary but educated guesses, not mathematical certainty. The virus, host response, and data will evolve. Biomedical and public health tools will expand, along with better understanding of their limitations. The incidence of SARS-CoV-2, vaccination rates, hospital capacity, tolerance for risk, and willingness to implement different interventions will vary geographically, and national recommendations will need to be adapted locally. It is imperative for public health, economic, and social functioning that US leaders establish and communicate specific goals for COVID-19 management, benchmarks for the imposition or relaxation of public health restrictions, investments and reforms needed to prepare for future SARS-CoV-2 variants and other novel viruses, and clear strategies to accomplish all of this. Redefining the Appropriate National Risk Level The goal for the "new normal" with COVID-19 does not include eradication or elimination, eg, the "zero COVID" strategy.^2 Neither COVID-19 vaccination nor infection appear to confer lifelong immunity. Current vaccines do not offer sterilizing immunity against SARS-CoV-2 infection. Infectious diseases cannot be eradicated when there is limited long-term immunity following infection or vaccination or nonhuman reservoirs of infection. The majority of SARS-CoV-2 infections are asymptomatic or mildly symptomatic, and the SARS-CoV-2 incubation period is short, preventing the use of targeted strategies like "ring vaccination." Even "fully" vaccinated individuals are at risk for breakthrough SARS-CoV-2 infection. Consequently, a "new normal with COVID" in January 2022 is not living without COVID-19. The "new normal" requires recognizing that SARS-CoV-2 is but one of several circulating respiratory viruses that include influenza, respiratory syncytial virus (RSV), and more. COVID-19 must now be considered among the risks posed by all respiratory viral illnesses combined. Many of the measures to reduce transmission of SARS-CoV-2 (eg, ventilation) will also reduce transmission of other respiratory viruses. Thus, policy makers should retire previous public health categorizations, including deaths from pneumonia and influenza or pneumonia, influenza, and COVID-19, and focus on a new category: the aggregate risk of all respiratory virus infections. What should be the peak risk level for cumulative viral respiratory illnesses for a "normal" week? Even though seasonal influenza, RSV, and other respiratory viruses circulating before SARS-CoV-2 were harmful, the US has not considered them a sufficient threat to impose emergency measures in over a century. People have lived normally with the threats of these viruses, even though more could have been done to reduce their risks. The appropriate risk threshold should reflect peak weekly deaths, hospitalizations, and community prevalence of viral respiratory illnesses during high-severity years, such as 2017-2018.^3 That year had approximately 41 million symptomatic cases of influenza, 710 000 hospitalizations and 52 000 deaths.^4 In addition, the CDC estimates that each year RSV leads to more than 235 000 hospitalizations and 15 000 deaths in the US.^3 This would translate into a risk threshold of approximately 35 000 hospitalizations and 3000 deaths (<1 death/ 100 000 population) in the worst week. Today, the US is far from these thresholds. For the week of December 13, 2021, the CDC reported the US experienced more than 900 000 COVID-19 cases, more than 50 000 new hospitalizations for COVID-19, and more than 7000 deaths.^5^,6 The tolerance for disease, hospitalization, and death varies widely among individuals and communities. What constitutes appropriate thresholds for hospitalizations and death, at what cost, and with what trade-offs remains undetermined. This peak week risk threshold serves at least 2 fundamental functions. This risk threshold triggers policy recommendations for emergency implementation of mitigation and other measures. In addition, health systems could rely on this threshold for planning on the bed and workforce capacity they need normally, and when to institute surge measures. Rebuilding Public Health To cope with pandemic, and eventually, endemic SARS-CoV-2 and to respond to future public health threats requires deploying real-time information systems, a public health implementation workforce, flexible health systems, trust in government and public health institutions, and belief in the value of collective action for public good.^7^,8 First, the US needs a comprehensive, digital, real-time, integrated data infrastructure for public health. As Omicron has reemphasized, the US is operating with imprecise estimates of disease spread, limited genomic surveillance, projections based on select reporting sites, and data from other countries that may not be generalizable. These shortcomings are threatening lives and societal function. The US must establish a modern data infrastructure that includes real-time electronic collection of comprehensive information on respiratory viral infections, hospitalizations, deaths, disease-specific outcomes, and immunizations merged with sociodemographic and other relevant variables. The public health data infrastructure should integrate data from local, state, and national public health units, health care systems, public and commercial laboratories, and academic and research institutions. Using modern technology and analytics, it is also essential to merge nontraditional environmental (air, wastewater) surveillance data, including genomic data, with traditional clinical and epidemiological data to track outbreaks and target containment. Second, the US needs a permanent public health implementation workforce that has the flexibility and surge capacity to manage persistent problems while simultaneously responding to emergencies. Data collection, analysis, and technical support are necessary, but it takes people to respond to crises. This implementation workforce should include a public health agency-based community health worker system and expanded school nurse system. A system of community public health workers could augment the health care system by testing and vaccinating for SARS-CoV-2 and other respiratory infections; ensuring adherence to ongoing treatment for tuberculosis, HIV, diabetes, and other chronic conditions; providing health screening and support to pregnant individuals and new parents and their newborns; and delivering various other public health services to vulnerable or homebound populations. School nurses need to be empowered to address the large unmet public health needs of children and adolescents. As polio vaccination campaigns showed, school health programs are an efficient and effective way to care for children, including preventing and treating mild asthma exacerbations (often caused by viral respiratory infections), ensuring vaccination as a condition for attendance, and addressing adolescents' mental and sexual health needs. School clinics must be adequately staffed and funded as an essential component of the nation's public health infrastructure. Third, because respiratory infections ebb and flow, institutionalizing telemedicine waivers, licensure to practice and enable billing across state lines, and other measures that allow the flow of medical services to severely affected regions should be a priority. Fourth, it is essential to rebuild trust in public health institutions and a belief in collective action in service of public health.^7 Communities with higher levels of trust and reciprocity, such as Denmark, have experienced lower rates of hospitalization and death from COVID-19.^7 Improving public health data systems and delivering a diverse public health workforce that can respond in real time in communities will be important steps toward building that trust more widely. Conclusions After previous infectious disease threats, the US quickly forgot and failed to institute necessary reforms. That pattern must change with the COVID-19 pandemic. Without a strategic plan for the "new normal" with endemic COVID-19, more people in the US will unnecessarily experience morbidity and mortality, health inequities will widen, and trillions will be lost from the US economy. This time, the nation must learn and prepare effectively for the future. The resources necessary to build and sustain an effective public health infrastructure will be substantial. Policy makers should weigh not only the costs but also the benefits, including fewer deaths and lost productivity from COVID-19 and all viral respiratory illnesses. Indeed, after more than 800 000 deaths from COVID-19, and a projected loss of $8 trillion in gross domestic product through 2030,^8 these interventions will be immensely valuable. Back to top Article Information Corresponding Author: Ezekiel J. Emanuel, MD, PhD, Medical Ethics and Health Policy, Perelman School of Medicine, University of Pennsylvania, 423 Guardian Dr, Blockley Hall, Philadelphia, PA 19104 (zemanuel@upenn.edu). Published Online: January 6, 2022. doi:10.1001/jama.2021.24282 Conflict of Interest Disclosures: Dr Emanuel reported personal fees, nonfinancial support, or both from companies, organizations, and professional health care meetings and being a venture partner at Oak HC/FT; a partner at Embedded Healthcare LLC, ReCovery Partners LLC, and COVID-19 Recovery Consulting; and an unpaid board member of Village MD and Oncology Analytics. Dr Emanuel owns no stock in pharmaceutical, medical device companies, or health insurers. No other disclosures were reported. Additional Information: Drs Emanuel, Osterholm, and Gounder were members of the Biden-Harris Transition COVID-19 Advisory Board from November 2020 to January 2021. References 1. Remarks by President Biden celebrating Independence Day and independence from COVID-19. July 4, 2021. https://bit.ly/3mJaGnQ 2. Gounder C. The progress of the Polio Eradication Initiative: what prospects for eradicating measles? Health Policy Plan. 1998;13 (3):212-233. PubMedGoogle ScholarCrossref 3. CDC Health Action Network. Increased interseasonal respiratory syncytial virus (RSV) activity in parts of the southern United States. June 10, 2021. Accessed November 8, 2021. https:// emergency.cdc.gov/han/2021/han00443.asp 4. National Center for Immunization and Respiratory Diseases. Estimated flu-related illnesses, medical visits, hospitalizations, and deaths in the United States--2017-2018 flu season. September 30, 2021. Accessed November 8, 2021. https://www.cdc.gov/flu/about/burden/ 2017-2018.htm 5. COVID Data Tracker Weekly Review. Reported cases. November 5, 2021. Accessed December 30, 2021. https://www.cdc.gov/coronavirus/2019-ncov /covid-data/covidview/index.html 6. JHU Coronavirus Resource Center. Weekly hospitalization trends. Updated November 8, 2021. https://coronavirus.jhu.edu/data/ hospitalization-7-day-trend/inpatient-capacity 7. Makridis CA, Wu C. How social capital helps communities weather the COVID-19 pandemic. PLoS One. 2021;16(1):e0245135. PubMedGoogle Scholar 8. Swagel P. Letter to Senate Majority Leader Schumer: comparison of CBO's May 2020 interim projections of gross domestic product and its January 2020 baseline projection. May 2020. Accessed November 8, 2021. https://www.cbo.gov/system/files/2020-06/56376-GDP.pdf Comment Limit 200 characters [ ] Limit 25 characters [ ] Conflicts of Interest Disclosure Identify all potential conflicts of interest that might be relevant to your comment. Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. Err on the side of full disclosure. If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response. Not all submitted comments are published. Please see our commenting policy for details. ( ) Yes, I have potential conflicts of interest. [ ] ( ) No, I do not have potential conflicts of interest. Limit 140 characters [ ] Limit 3600 characters or approximately 600 words [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] Submit Please Wait... The following information is required and must be completed in order to submit a comment: Thank You. Your comment submission was successful. Please allow up to 2 business days for review, approval, and posting. JAMA 4 Comments for this article EXPAND ALL January 7, 2022 Primary Care at the Center of the New Normal Howard Haft, MD, MMM | Maryland Department of Health The authors provide a credible description of the future of our relationship with Covid-19 and a nearly complete list of the actions that are needed to cope with the new reality and be prepared for future threats. However the largest part of the healthcare delivery system was notably absent on this list, the primary care workforce. Primary care, when well resourced and integrated with public health, provides the ability to implement public health strategies broadly across states and jurisdictions. Widely deployed, capable of immunizing populations, testing for both surveillance and treatment, and highly trusted communicators of mitigation strategies, this workforce has the capability of filling in many of the gaps in the current public health system. For example, the broadly implemented Maryland Primary Care Program has demonstrated how bringing public health tools and resources to primary care can amplify and support public health response to a pandemic, amplifying the coordinated statewide response to testing, vaccination and therapeutics. As we contemplate the future of the overall healthcare delivery system in the USA , integrating primary care with public health should be a key initiative, with primary care serving as a public good. CONFLICT OF INTEREST: None Reported READ MORE January 7, 2022 Brilliant Judy Malmgren, PhD Epidemiology | University of Washington I have been thinking along these same lines for months. So glad someone else wrote the piece! We need to reestablish the public health traineeship program in Schools of Public Health that paid part of my tuition to become an epidemiologist. We need replacements for me and my cohort as we retire, but with an increase in numbers. Systems and infrastructure that function on a large scale need to be built that can handle millions of cases. Already the reporting scales used by health departments are inadequate. Build the infrastructure - we need it desperately. CONFLICT OF INTEREST: None Reported January 7, 2022 A National Strategy for a Disunited Nation? Steven Livesey, History of Science | University of Oklahoma In their paper, the authors urge the creation of a new national strategy to look beyond the current Covid-19 crisis and to bring Covid responses into a larger, more robust public health system. They assert, "To cope with pandemic, and eventually endemic SARS-CoV-2, and to respond to future public health threats requires deploying real-time information systems, a public health implementation workforce, flexible health systems, trust in government and public health institutions, and belief in the value of collective action for public good." These are laudable goals and certainly recognitions of necessary components. But nowhere in their essay do the authors tell us how we are to achieve trust in government and belief in the value of collective action for public good. On the anniversary of the January 6 insurrection, we seem to be very far from this collective purpose, and no one seems to have a feasible plan to rebuild the trust that has been eroding for at least the past 2 generations. We cannot convince sizable populations to adopt basic public health strategies like wearing masks in close interior spaces, and state governments across the country are actively opposing mitigation strategies that the authors suggest. Until the authors augment their paper by explaining how to heal the disunity so prevalent in modern America, I see little in the recommendations here that will be implemented successfully. CONFLICT OF INTEREST: None Reported READ MORE January 7, 2022 Endorsement and Integration with Mental Health Care John P. Glazer, MD | Child and Adolescent Psychiatry All Americans, and the medical provider community who serve our citizens, owe Dr. Emanuel and his colleagues a debt of gratitude. It is not comfortable to speak out so directly but absolutely necessary in the health crisis we all face. I urge all Americans to take the authors' specific recommendations with the utmost seriousness and the Biden administration to immediately open communication channels with these distinguished physician members of the former Biden transition team; and urge that the burden COVID, flu, and other respiratory viruses pose for Americans with limited resources, and those dealing with depression, anxiety, and suicidal feelings, particularly children and teens, be directly addressed, with desperately needed treatment resources directed to them. CONFLICT OF INTEREST: None Reported READ MORE See More About Coronavirus (COVID-19) Infectious Diseases Public Health Download PDF Cite This Citation Emanuel EJ, Osterholm M, Gounder CR. A National Strategy for the "New Normal" of Life With COVID. JAMA. Published online January 06, 2022. doi:10.1001/jama.2021.24282 Download citation file: Ris (Zotero) EndNote BibTex Medlars ProCite RefWorks Reference Manager Mendeley (c) 2022 Permissions Comment Coronavirus Resource Center Others Also Liked X JAMA Content Home New Online Current Issue Podcasts Coronavirus (COVID-19) Q&A Clinical Reviews Editors' Summary Medical News Author Interviews Performance Improvement: Do No Harm Professionalism: Best Practice JAMAevidence: Care at the Close of Life JAMAevidence: JAMA Guide to Statistics and Methods JAMAevidence: The Rational Clinical Examination JAMAevidence: Users' Guides to the Medical Literature Journal Information For Authors Editors & Publishers RSS Contact Us JN Learning / CME Store Apps Jobs Institutions Reprints & Permissions Journal Cover Subscribe Go JAMA Network Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology-Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Sites Art and Images in Psychiatry Best of the JAMA Network Clinical Crosswords from JAMA Coronavirus Resource Center Digital Media Editorial Fellowship Evidence-Based Medicine: An Oral History Fishbein Fellowship Genomics and Precision Health Hypertension JAMA Forum Archive JAMA Network Audio JAMA Network Conferences Machine Learning Research Ethics Topics and Collections Special Communications FDA Approval and Regulation of Pharmaceuticals, 1983-2018 Global Burden of Cancer, 1990-2017 Global Burden of Skin Diseases, 1990-2017 Global Firearm Mortality, 1990-2016 Health Care Spending in the US and Other High-Income Countries Life Expectancy and Mortality Rates in the United States, 1959-2017 Medical Marketing in the United States, 1997-2016 Practices to Foster Physician Presence and Connection With Patients in the Clinical Encounter President Obama on US Health Care Reform The State of US Health, 1990-2016 US Burden of Cardiovascular Disease, 1990-2016 US Burden of Neurological Disease, 1990-2017 Waste in the US Health Care System: Estimated Costs and Potential for Savings Blogs AMA Style Insider Information For Authors For Institutions & Librarians For Advertisers For Subscription Agents For Employers & Job Seekers For the Media Statement on Potentially Offensive Content JAMA Network Products AMA Manual of Style JAMAevidence JN Listen Peer Review Congress JN Learning Home CME Quizzes State CME Audio / Podcast Courses Clinical Challenge CME Atrial Fibrillation Course Marijuana Course Penicillin Allergy Course Cervical Cancer Screening Course CME / MOC Reporting Preferences About CME & MOC Help Subscriptions & Renewals Email Subscriptions Update Your Address Contact Us Frequently Asked Questions JAMA Career Center Physician Job Listings Get the latest from JAMA [ ] Sign Up Privacy Policy | Terms of Use Jama Network Logo (c) 2022 American Medical Association. All Rights Reserved. Terms of Use| Privacy Policy| Accessibility Statement Silverchair Logo . x Access your subscriptions --------------------------------------------------------------------- Sign in | personal account Seamless Access Logo Access through your institution Add or change institution Free access to newly published articles --------------------------------------------------------------------- Create a free personal account To register for email alerts with links to free full-text articles Purchase access --------------------------------------------------------------------- Subscribe to journal Get full journal access for 1 year Buy article Get unlimited access and a printable PDF ($30.00)-- Sign in or create a free account Rent article Rent this article from DeepDyve Access your subscriptions --------------------------------------------------------------------- Sign in | personal account Seamless Access Logo Access through your institution Add or change institution Free access to newly published articles --------------------------------------------------------------------- Create a free personal account To register for email alerts with links to free full-text articles Purchase access --------------------------------------------------------------------- Subscribe to journal Get full journal access for 1 year Buy article Get unlimited access and a printable PDF ($30.00)-- Sign in or create a free account Rent article Rent this article from DeepDyve Access to free article PDF downloads --------------------------------------------------------------------- Sign in | personal account Seamless Access Logo Access through your institution Add or change institution Free access to newly published articles --------------------------------------------------------------------- Create a free personal account To register for email alerts with links to free full-text articles Save your search --------------------------------------------------------------------- Sign in | personal account Free access to newly published articles --------------------------------------------------------------------- Create a free personal account To register for email alerts with links to free full-text articles Purchase access --------------------------------------------------------------------- Subscribe now Customize your interests --------------------------------------------------------------------- Sign in | personal account Free access to newly published articles --------------------------------------------------------------------- Create a free personal account To register for email alerts with links to free full-text articles Create a personal account or sign in to: * Register for email alerts with links to free full-text articles * Access PDFs of free articles * Manage your interests * Save searches and receive search alerts Privacy Policy Make a comment ------------------------------------------------------------- Sign in | personal account Free access to newly published articles ------------------------------------------------------------- Create a free personal account To register for email alerts with links to free full-text articles Create a personal account or sign in to: o Register for email alerts with links to free full-text articles o Access PDFs of free articles o Manage your interests o Save searches and receive search alerts Privacy Policy